Descriptor: "SERIAL publications" / Journal: headache: the journal of head & face pain / Publisher: wiley-blackwell / Topic: therapeutics - Searchworks@Jio Institute Digital Library Search Results

Author: Buse, Dawn C., Greisman, Jacob D., Baigi, Khosrow, and Lipton, Richard B.
Subjects: *MIGRAINE diagnosis, *MIGRAINE prevention, *NEUROTRANSMITTERS, *AGE factors in disease, *BEHAVIOR modification, *BEHAVIOR therapy, *BLOOD sugar monitoring, *MENTAL depression, *HEALTH behavior, *HYPERTENSION, *MEDICAL practice, *PATIENT education, *PUBLIC health, *QUALITY of life, *RISK assessment, *SERIAL publications, *COMORBIDITY, *DISEASE progression, *EPIGENOMICS, *THERAPEUTICS, MIGRAINE risk factors
Abstract: The article offers information on the hypothesis for migraine progression in which risk factors are linked to persistent activation of the trigeminovascular pathway. It discussed prevention and treatment of chronic migraine (CM) that may be achieved through interventions which prevent trigeminovascular activation.
Published: 2019
Full Text: View/download PDF

Author: Landy, Stephen H.
Subjects: *HEADACHE treatment, *TENSION headache, *PLACENTA diseases, *LABOR complications (Obstetrics), *AUTHORSHIP, *CARDIOVASCULAR diseases, *HEADACHE, *MAGNETICS, *MANIPULATION therapy, *MIGRAINE, *PARANASAL sinuses, *PUBLISHING, *SERIAL publications, *DISEASE remission, *DISEASE risk factors, *THERAPEUTICS, PREGNANCY complication risk factors, RISK factors
Abstract: The article offers information on manuscripts published in peer review journals, other than "Headache: The Journal of Head & Face Pain." One concerns a population-based study of migraine and cardiovascular disease. Another deals with sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers. Another one is about rates, predictors, and consequences of remission from chronic migraine to episodic migraine.
Published: 2012
Full Text: View/download PDF

Author: Schwedt, Todd J.
Subjects: *MIGRAINE prevention, *SEROTONIN agonists, *CELL receptors, *CALCITONIN, *CLUSTER headache, *DRUG tolerance, *HEADACHE, *MIGRAINE, *SERIAL publications, *TREATMENT effectiveness, *ACUTE diseases, *CHEMICAL inhibitors, *THERAPEUTICS
Abstract: An introduction is presented in which the editor discusses articles in the issue on topics including acute treatment of migraine attacks, use of target calcitonin gene-related peptide (CGRP) for migraine, and clinical trials of 5HT-1F receptor agonists.
Published: 2019
Full Text: View/download PDF

Author: Silberstein, Stephen D.
Subjects: *PANCREATIC hormones, *ALEXITHYMIA, *CELL receptors, *CEREBRAL arteries, *CLUSTER headache, *COGNITION, *MIGRAINE, *NEURONS, *NEUROPEPTIDES, *NEUROTRANSMITTERS, *NOCICEPTORS, *OXYTOCIN, *PEPTIDE hormones, *SERIAL publications, *PRIMARY headache disorders, *THERAPEUTICS
Abstract: The article discusses the topics covered during the 2016 Scottsdale Headache Symposium. Topics covered include the discovery of the role of calcitonin gene-related peptide in migraine, the role of pituitary adenylate cyclase-activating peptide-38 in migraine and cluster headache, and the rationale for the use of intranasal oxytocin in the treatment of migraine headache.
Published: 2017
Full Text: View/download PDF

Author: Purdy, R. Allan
Subjects: *TRYPTAMINE, *MIGRAINE, *SERIAL publications, *THERAPEUTICS
Abstract: The author discusses triptan usage in Canadian provinces. Topics discussed include use of triptans as a safe and effective method for acute migraine treatment, the effect of public drug coverage on pharmacoeconomics and triptan usage patterns, and the free health care services offered by physicians and hospitals in some provinces in the country.
Published: 2015
Full Text: View/download PDF

Author: Ward, Thomas N.
Subjects: *MIGRAINE prevention, *PHARMACEUTICAL industry & ethics, *GABAPENTIN, *SERIAL publications, *RESEARCH bias, *THERAPEUTICS
Abstract: The article focuses on a controversy related to the article "Efficacy of gabapentin in migraine prophylaxis" by N.T. Mathew and colleagues in a previous issue. Mathew and colleagues do not desire to retract the above article and deny any misrepresentation on their part. The data analysis for the article consisted of an intention-to-treat analysis performed on a research group from which some patients had been deleted instead of the pre-specified primary outcome measure.
Published: 2014
Full Text: View/download PDF

Author: Tepper, Stewart J.
Subjects: *HEADACHE treatment, *CEREBROSPINAL fluid, *INTRACRANIAL hypertension, *HEADACHE, *SERIAL publications, *DIAGNOSIS, *THERAPEUTICS
Abstract: An introduction is presented in which the editor two reports within the issue on topics such as diagnosis with ophthalmologic concerns for idiopathic intracranial hypertension and low cerebrospinal fluid (CSF) pressure headaches, and treatment options.
Published: 2014
Full Text: View/download PDF

Author: Tepper, Stewart J.
Subjects: *INDOMETHACIN, *HEADACHE, *SERIAL publications, *THERAPEUTICS
Abstract: An introduction is presented in which the editor discusses various reports within the issue on topics including "The Pharmacology of Indomethacin" by Sylvia Lucas, and fascinating potpourri of headache topics related to indomethacin in literature world by Emilia and Carlos Bordini.
Published: 2016
Full Text: View/download PDF

Author: Rothrock, John F.
Subjects: *BOTULINUM toxin, *THERAPEUTICS, *EDITORS, *MIGRAINE, *POLICY sciences, *SERIAL publications, *RESEARCH bias
Abstract: The author discusses his Lagniappe which addressed the use of onabotulinumtoxinA to suppress chronic migraine; and highlights that according to a reader he did not disclose any potential conflicts of interest in regards to the drug and its application. He informs that the journal's editor in chief is required annually to disclose any and all potential conflicts of interest, and onabotulinumtoxinA being a controversial therapy needs rigorous standard for disclosure.
Published: 2012
Full Text: View/download PDF

Searchworks